EQS Team-Ad-hoc: Zur Rose Team AG / Vital term(s): Tender Give
Zur Rose Team: gematik awards tender for expert e-prescription services – Zur Rose subsidiary eHealth-Tec concerned as associate to IBM
16-Nov-2020 / 15:28 CET/CEST
Launch of an advert hoc announcement pursuant to Artwork. 53 KR
The issuer is exclusively dependable for the material of this announcement.
Ad hoc announcement
gematik awards tender for expert e-prescription provider – Zur Rose subsidiary eHealth-Tec concerned as companion to IBM
eHealth-Tec GmbH, a German subsidiary of the Zur Rose Team of Switzerland, took portion in the tender by gematik, the software program services service provider of the Federal Ministry of Wellness, for “provision of enhancement services, personal computer centre infrastructure, procedure components and computer software as element of the launch of e-prescriptions” with IBM Deutschland GmbH as its lover. gematik nowadays introduced that IBM has received the tender for the specialist e-prescription assistance. eHealth-Tec is concerned in the implementation as a husband or wife to IBM. This consists of offering the essential infrastructure and working and supporting the components and program parts. The specialist e-prescription provider has to be designed and intended to be able to system the full quantity of e-prescriptions issued in Germany and have scope for even further expansion.
eHealth-Tec performs as a technological innovation supplier in strategic partnerships with wellness insurers and other individuals in the health care field to properly employ pilot e-prescription initiatives that are applicable to the market. eHealth-Tec contributed its accrued practical experience as a programs supplier for e-prescription answers in the IBM submission. The thriving participation in the gematik tender reinforces the part played by the Zur Rose Team as a pioneer in effectively introducing digital prescriptions in Germany.
Investors and analyst get hold of
Christoph Herrmann, Head of Trader Relations
E-mail: [email protected], cellphone: +41 58 810 11 49
Media contacts
Zur Rose Group:
Lisa Lüthi, Head of Group Communications
Email: [email protected], cell phone: +41 52 724 08 14
Phase Germany of the Zur Rose Group:
Torben Bonnke, Director Interaction & PR
Electronic mail: [email protected], cellphone +49 30 21222 36 12
Agenda
21 January 2021 Income 2020
18 March 2021 2020 Comprehensive-Calendar year Effects
20 April 2021 Very first Quarter Investing Update
29 April 2021 Once-a-year General Meeting
Zur Rose Group
The Swiss Zur Rose Group is Europe’s premier e-commerce pharmacy and one of the top professional medical wholesalers in Switzerland. It also operates the top market in southern Europe for shopper wellness, beauty and personal treatment products typically offered in pharmacies. The firm is internationally existing with strong models, like Germany’s very best-acknowledged pharmacy model DocMorris. Zur Rose employs additional than 1,800 folks at websites in Switzerland, Germany, the Netherlands, Spain and France. In 2019 it created revenue of CHF 1,569 million (which include medpex) and presently has all around ten million lively clients in main European marketplaces.
With its business model, the Zur Rose Group offers superior-good quality, safe and charge-productive pharmaceutical care. It is also characterised by the continual more development of digital solutions in the area of drug management making use of AI-supported applications and new technological innovation. Zur Rose is moreover actively driving ahead its positioning as a complete company of health care products and services. By creating a digital healthcare platform – the Zur Rose ecosystem – it networks items and electronic services from skilled companies. The contribution designed by Zur Rose will be to acquire these offerings to clients and sufferers and to make a relevant choice. The intention is to give men and women with a seamless accompaniment and empower them to regulate their very own wellbeing optimally working with merchandise and digital options.
The shares of Zur Rose Team AG are outlined on the Six Swiss Exchange (securities number 4261528, ISIN CH0042615283, ticker ROSE). For more info you should see zurrosegroup.com.
Stop of advert hoc announcement
Data and Rationalization of the Issuer to this Information:
Ad hoc announcement
gematik awards tender for expert e-prescription company – Zur Rose subsidiary eHealth-Tec included as partner to IBM
eHealth-Tec GmbH, a German subsidiary of the Zur Rose Team of Switzerland, took component in the tender by gematik, the application assistance service provider of the Federal Ministry of Health, for ‘provision of development providers, computer system centre infrastructure, system components and software package as section of the launch of e-prescriptions’ with IBM Deutschland GmbH as its lover. gematik today introduced that IBM has gained the tender for the specialist e-prescription service. eHealth-Tec is associated in the implementation as a associate to IBM. This involves giving the needed infrastructure and functioning and supporting the hardware and software package elements. The expert e-prescription assistance has to be formulated and created to be equipped to course of action the entire volume of e-prescriptions issued in Germany and have scope for even further growth.
eHealth-Tec works as a know-how supplier in strategic partnerships with overall health insurers and many others in the health care market to effectively employ pilot e-prescription initiatives that are related to the marketplace. eHealth-Tec contributed its accumulated encounter as a devices service provider for e-prescription answers in the IBM submission. The effective participation in the gematik tender reinforces the role played by the Zur Rose Group as a pioneer in properly introducing electronic prescriptions in Germany.
Buyers and analyst call
Christoph Herrmann, Head of Investor Relations
E-mail: [email protected], cell phone: +41 58 810 11 49
Media contacts
Zur Rose Team:
Lisa Lüthi, Head of Team Communications
E-mail: [email protected], phone: +41 52 724 08 14
Segment Germany of the Zur Rose Group:
Torben Bonnke, Director Interaction & PR
E-mail: [email protected], mobile phone +49 30 21222 36 12
Agenda
21 January 2021 Product sales 2020
18 March 2021 2020 Entire-Year Results
20 April 2021 Initial Quarter Buying and selling Update
29 April 2021 Annual Common Assembly
Zur Rose Group
The Swiss Zur Rose Group is Europe’s major e-commerce pharmacy and one of the major healthcare wholesalers in Switzerland. It also operates the main marketplace in southern Europe for purchaser overall health, magnificence and personalized care goods commonly marketed in pharmacies. The organization is internationally present with robust models, including Germany’s greatest-known pharmacy model DocMorris. Zur Rose employs additional than 1,800 folks at websites in Switzerland, Germany, the Netherlands, Spain and France. In 2019 it created revenue of CHF 1,569 million (together with medpex) and at the moment has close to ten million active prospects in core European markets.
With its organization model, the Zur Rose Team delivers superior-high quality, harmless and cost-successful pharmaceutical care. It is also characterized by the continual even more enhancement of electronic providers in the discipline of drug management applying AI-supported apps and new engineering. Zur Rose is additionally actively driving ahead its positioning as a complete provider of health care expert services. By generating a electronic health care platform – the Zur Rose ecosystem – it networks products and digital providers from capable providers. The contribution manufactured by Zur Rose will be to consider these choices to customers and individuals and to make a related variety. The goal is to supply people with a seamless accompaniment and empower them to manage their individual wellbeing optimally applying products and solutions and electronic alternatives.
The shares of Zur Rose Group AG are detailed on the 6 Swiss Trade (securities number 4261528, ISIN CH0042615283, ticker ROSE). For even further information you should see zurrosegroup.com.
